Angiotensin-converting enzyme gene polymorphism in systemic hypertension

American Journal of Cardiology

Volumn 81, Issue 2, 1998, Pages 244-246

  Abbud, Ziad A ^a   Wilson, Alan C ^a   Cosgrove, Nora M ^a   Kostis, John B ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DNA;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; DNA; DNA PROBES; GENOTYPE; HUMANS; HYPERTENSION; MIDDLE AGED; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RANDOM ALLOCATION; REPRODUCIBILITY OF RESULTS;

EID: 0032518811     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00876-X     Document Type: Article

References (20)

1. 1. Perusse L, Moll PP, Sing CF. Evidence that a single gene with gender-and age-dependent effects influences systolic blood pressure determination in a population-based sample. Am J Hum Genet 1991;49:94-105.
2. 2. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1433.
3. 3. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme in a potent risk factor for myocardial infarction. Nature 1992;359:641-644.
4. 4. Raynolds MV, Bristow, MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perryman MB. Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 1993;342: 1073-1075.
5. 5. Summers KM, West JA, Huggard PR, West MJ. Angiotensin converting enzyme gene and regulation of blood pressure in a large Australian family. Clin Exp Pharmacol Physiol 1993;20:320-325.
6. 6. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Amouyel P, Kee F, Nicaud V, Evans A, Cambou J, Luc G, Cambien F. Deletion polymorphism in angiotensin converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993;341:991-992.
7. 7. Berge KE, Berg K. No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability. Clin Genet 1994;45:169-174.
8. 8. Schmidt S, van Hooft IM, Grobbee DE, Ganten D, Ritz E. Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch hypertension and offspring study. J Hypertens 1993;11:345-348.
9. 9. Duru K, Farrow S, Wang JM, Lockette W, Kurtz T. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in african-americans with hypertension. Am J Hypertens 1994;7:759-762.
10. 10. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, Miki T, Mikami H, Ogihara T. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun 1993;191:399-404.
11. 11. Zee RYZ, Lo Y, Griffiths LR, Morris BJ: Association of a polymorphism of the angiotensin I converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992;184:9-15.
12. 12. Morris BJ, Zee RY, Schrader AP. Different frequencies of angiotensin converting enzyme genotypes in older hypertensive individuals. J Clin Invest 1994;94:1085-1089.
13. 13. Gharavi AG, Lipkowitz MS, Diamond JA, Jhang JS, Phillips RA. Deletion polymorphism of the angiotensin converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am J Cardiol 1996;77:1315-1319.
14. 14. Harrap SB, Davidson FTR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJ, Watt GC. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993;21:455-460.
15. 15. Wierzbicki AS, Nimmo L, Feher MD, Cox A, Foxton J, Lant AF. Association of angiotensin converting enzyme DD genotype with hypertension in diabetes. J Hum Hypertens 1995;9:671-673.
16. 16. Appel L, Espeland M, Whelton P, Dolecek T, Kumanyika S, Applegate W, Ettinger W, Kostis J, Wilson A, Lacy C, Miller S. Trial of nonpharmacologic intervention in the elderly (TONE): design and rationale of a blood pressure control trial. Ann Epidemiol 1995;5:119-129.
17. 17. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F. A deletion polymorphism in the ACE gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis 1995;112:137-143.
18. 18. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/ deletion polymorphism in the angiotension I-converting enzyme gene accounting for half of the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
19. 19. Ishigami T, Iwamoto T, Tamura K, Yamaguchi S, Iwasawa K, Uchino K, Umemura S, Ishii M. Angiotensin I converting enzyme gene polymorphism and essential hypertension in Japan. Am J Hypertens 1995;8:95-97.
20. 20. Jeunemaitre X, Lifton RP, Hunt SC, Williams, Hunt SC. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet 1992;1:72-75.